How would defining Parkinson's as a prion disease impact the search of a cure?
Expert Rev Neurother
.
2020 May;20(5):417-420.
doi: 10.1080/14737175.2020.1753504.
Epub 2020 Apr 17.
Authors
Carlo Scialò
1
,
Giuseppe Legname
1
Affiliation
1
Department of Neuroscience, Laboratory of Prion Biology, Scuola Internazionale Superiore Di Studi Avanzati (SISSA), Trieste, Italy.
PMID:
32253950
DOI:
10.1080/14737175.2020.1753504
No abstract available
Keywords:
Parkinson’s disease; neurodegeneration; prion; therapy; α-synuclein.
Publication types
Editorial